Skip to search formSkip to main contentSkip to account menu

blonanserin

Known as: 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine, Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro- 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

AD 5423lonasen

Broader (2)

PiperazinesPiperidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Montmorillonite-lipid hybrid carriers for ionizable and neutral poorly water-soluble drugs: Formulation, characterization and in vitro lipolysis studies.
2016
2016
Effect of isopropyl myristate on the viscoelasticity and drug release of a drug-in-adhesive transdermal patch containing blonanserinEffect of isopropyl myristate on the viscoelasticity and drug…
2015
2015
Blonanserin Ameliorates Phencyclidine-Induced Visual-Recognition Memory Deficits: the Complex Mechanism of Blonanserin Action Involving D3-5-HT2A and D1-NMDA Receptors in the mPFC
Blonanserin differs from currently used serotonin 5-HT2A/dopamine-D2 receptor antagonists in that it exhibits higher affinity for… 
2015
2015
The serotonin 5-HT1A receptor agonist tandospirone improves executive function in common marmosets
Highly Cited
2014
Highly Cited
2014
Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5‐HT)2A and DA D2 antagonism and 5‐HT1A partial agonism
Atypical antipsychotic drugs (AAPDs) have been suggested to be more effective in improving cognitive impairment in schizophrenia… 
Highly Cited
2013
Highly Cited
2013
Profile of blonanserin for the treatment of schizophrenia
Blonanserin was developed as an antipsychotic drug in Japan and approved for the treatment of schizophrenia. It belongs to a… 
2013
2013
Striatal and Extrastriatal Dopamine D2 Receptor Occupancy by a Novel Antipsychotic, Blonanserin: A PET Study With [11C]Raclopride and [11C]FLB 457 in Schizophrenia
Abstract Blonanserin is a novel antipsychotic with high affinities for dopamine D2 and 5-HT2A receptors, and it was recently… 
2010
2010
Effect of dose timing in relation to food intake on systemic exposure to blonanserin
PurposeBlonanserin is a novel potent dopamine D2 and serotonin 5-HT2 antagonist for treating schizophrenia. The aim of this study… 
Highly Cited
2009
Highly Cited
2009
The Efficacy and Safety of Blonanserin Compared with Haloperidol in Acute-Phase Schizophrenia
AbstractBackground: Blonanserin is a novel atypical antipsychotic agent with potent dopamine D2 and serotonin 5-HT2 antagonist… 
2004
2004
Atypical properties of several classes of antipsychotic drugs on the basis of differential induction of Fos-like immunoreactivity in the rat brain.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)